Bender Robert & Associates
Source: SEC Form 13F · as of Mar 2026Bender Robert & Associates holds 11 biotech & pharma companies tracked by BioSniper, totaling $31.5M in value as of Mar 2026 (SEC Form 13F).
Companies held
11
Total value held
$31.5M
| Company | Shares | Value |
|---|---|---|
| LLYELI LILLY & Co | 17,554 | $16.1M |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 26,171 | $11.7M |
| JNJJOHNSON & JOHNSON | 3,224 | $788K |
| URGNUroGen Pharma Ltd. | 34,701 | $624K |
| ABBVAbbVie Inc. | 2,393 | $520K |
| MRKMerck & Co., Inc. | 4,077 | $490K |
| GILDGILEAD SCIENCES, INC. | 2,819 | $393K |
| ABTABBOTT LABORATORIES | 2,905 | $298K |
| PLSEPulse Biosciences Inc Common Stock (DE) | 12,190 | $263K |
| BCRXBIOCRYST PHARMACEUTICALS INC | 23,710 | $226K |
| EOLSEvolus, Inc. | 25,070 | $103K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.